It remains to be proven whether left ventricular (LV) peak systolic velocity indices (peak systolic annulus tissue velocities, ejection velocity, and strain rate) are more closely related to contraction than LV end-systolic echocardiographic indices (ejection fraction, fractional shortening, systolic annulus displacement, global strain, and ejection velocity time integral). The study aimed to compare the ability of different echocardiographic methods in detecting contraction changes of the LV.
Introduction
Myocardial systolic function depends upon the interaction of myocardial contractility, preload, and afterload. Force development (contractility of the myocytes) which generates sufficient pressure to open the cardiac valves should be distinguished from deformation (shortening of the myocytes) which gives rise to the actual volume ejection. 1 True contractility of the myocardium is currently not measurable non-invasively in clinical practice. 1 However, myocyte contraction occurs in the first part of systole, which corresponds well to the timing of the echocardiographic peak systolic velocity indices such as peak systolic annulus tissue velocities, ejection velocity, and peak systolic strain rate, but it is still questionable whether these indices are closely related to contraction. In contrast to force development, deformation and volume ejection continue until the end of systole, and end-systolic echocardiographic indices such as ejection fraction, fractional shortening (FS), systolic mitral annulus displacement, global strain and the ejection velocity time integral have been shown to be closely related to deformation and stroke volume. 2, 3 We hypothesized that peak systolic velocity indices better reflect changes in contraction compared with end-systolic indices and aimed to test whether these indices responded differently to inotropic alterations.
Methods

Study population
After local advertisement, we prospectively recruited 33 (25 males and 8 women) healthy volunteers (20-32 years), height 179 [standard deviation (SD 8)] cm and weight 75 (SD 12) kg. The study was approved by the Regional Committee for Medical Research Ethics and conducted according to the Helsinki Declaration. Written informed consent was obtained. The subjects were free from medications, known cardiovascular disease, structural heart disease, diabetes, or hypertension. All participants had normal electrocardiogram (ECG) and echocardiogram at rest. None were excluded due to inadequate echocardiographic image quality.
Study design
All examinations were conducted by one experienced physician echocardiographer (A.T.). A complete echo/Doppler study at rest was performed in all the participants. Low-dose dobutamine stress echocardiography was performed in 13 subjects. Both low-dose dobutamine stress echocardiography and echocardiography after intravenous administration of metoprolol were performed in seven subjects. Echocardiography after intravenous administration of metoprolol was performed on 13 subjects. In total, 20 paired restdobutamine recordings and 20 paired rest-metoprolol recordings were obtained and the subsequent measurements were categorized into three contractile states: b-blocker, rest, or dobutamine.
The low-dose dobutamine protocol started with a dose of 5 mg/kg/min for 3 min, followed by 10 mg/kg/min until the recordings were completed. The recordings during 10 mg/kg/min dobutamine infusion started after 3 min of steady state. For the b-blocker study, 15 mg of metoprolol was injected over 10 min, and a new complete echo/Doppler study started 10 min after the last injection. For those who received both dobutamine and metoprolol, the recordings after infusion of metoprolol started 20 min after the infusion of dobutamine was ended.
Echocardiographic image acquisition
All examinations were performed in the left lateral decubitus position with a Vivid 7 scanner (version BT09, GE Vingmed Ultrasound, Horten, Norway) using a 2.0 MHz phased-array matrix transducer (M3S) for the two-dimensional (2D) recordings and a 2.0 MHz vector-array transducer (3V) for the three-dimensional (3D) recordings. For each 2D view, three consecutive cardiac cycles were recorded during quiet respiration. From the three apical views, separate B-mode acquisitions (mean frame rate 50 s
21
) and colour tissue Doppler (TD) acquisitions (mean frame rate 110 s
) were recorded. The left ventricular outflow tract (LVOT) velocity was recorded from the apical five-chamber view with the sample volume positioned about 5 mm proximal to the aortic valve. Pulsed-wave Doppler mitral flow velocities were recorded from the apical four-chamber view with the sample volume between the leaflet tips. Spectral TD mitral annular velocities were acquired from the base of the septal, lateral, inferior, and anterior walls in the four-and two-chamber views. A 6 mm sample volume was positioned within 1 cm of the insertion of the mitral leaflets. 4 Real-time 3D echocardiography recordings were preformed immediately after the 2D examination. From the apical approach, four to six consecutive ECG-gated subvolumes were acquired during end-expiratory apnoea to generate full-volume data sets (mean frame rate 26 s 21 ). Care was taken to encompass the entire LV cavity and, if unsatisfactory, the data set was re-acquired.
Analysis of B-mode and Doppler echocardiography
LV volumes and LV ejection fraction (LVEF) were measured by biplane Simpson's rule from the apical four-and two-chamber views. Enddiastolic volume was measured at the time of mitral valve closure, and end-systolic volume was measured on the image with the smallest LV cavity. LV internal end-diastolic and end-systolic dimensions were measured perpendicular to the long axis of the ventricle at the mitral valve leaflet tips in the parasternal long-axis view, using anatomical M-mode echocardiography. The FS was calculated as the difference between LV internal end-diastolic and end-systolic dimensions divided by the LV internal end-diastolic dimension. LVEF was also obtained from the 3D recordings (4D auto LV quantification, version BT11, GE Vingmed Ultrasound). End-diastolic and end-systolic volumes were measured after manual alignment followed by automatic detection of endocardial surface which were manually adjusted by placing as many additional points as needed in 3D at both end-diastole and end-systole. Finally, the automatically detected epicardial borders were manually adjusted in 3D at end-diastole in order to calculate LV mass.
From the spectral TD recordings, peak systolic mitral annular velocities [S ′ (spectral TD)] were measured at the peak of the Doppler spectrum with a low gain setting ( Figure 1A) . Peak systolic mitral annular velocities were also measured by colour TD [S ′ (colour TD)] ( Figure 1B) . Systolic mitral annular excursion (MAE) was measured using anatomical M-mode echocardiography from the apical position [MAE (M-mode)] ( Figure 1C) and from TD by integration of the velocity curves [MAE (colour TD)] ( Figure 1C) . The annular plane motion and velocity indices of the septal, lateral, inferior, and anterior walls were averaged to give global measurements of LV performance.
The LVOT peak velocity was measured from the LVOT spectrum using a low gain setting. The LVOT velocity time integral (vti) was measured by tracing the modal velocity throughout systole ( Figure 1D ). All indices reflected the average of three cardiac cycles during quiet respiration.
Analysis of deformation indices
Segmental longitudinal strain and strain rate were measured in the three standard apical views.
Longitudinal end-systolic strain was obtained by speckle tracking in grey-scale recordings by 2D speckle-tracking echocardiography (2D-ST) (Automated Function Imaging; EchoPAC PC version BT 09, GE Vingmed, Horten, Norway). The regions of interest (ROIs) were manually adjusted to include the entire LV myocardium and simultaneously avoid the pericardium ( Figure 1E ). Segments with poor tracking were excluded manually. End-systolic strain was measured at the automatically detected aortic valve closure (manually corrected if necessary).
Longitudinal strain rate was calculated from colour TD recordings, using the TD velocity gradient along the ultrasound beam (Q-Analysis; EchoPAC PC version BT 09, GE Vingmed). For each segment, a Contraction changes assessed by echocardiography in young healthy humans stationary ROI with offset length 12 mm was manually positioned in the middle of the myocardium. The ROI was adjusted up to 10 mm longitudinally and 5 mm laterally in order to avoid noise. Peak systolic strain rate (SR S ) was measured as the maximal negative value during ejection time and reflected the average of three cardiac cycles.
Segmental longitudinal strain and SR S (TD) were analysed in an 18-segment model of the LV, and global averages were calculated from the standard ASE 16-segment model. 5 
Statistics
Values are reported as mean and SD. Calculation of the relative change (the measured difference between rest and the different contractile states, divided by the measurement at rest) was done for all echocardiographic indices. For multiple comparisons, one-way ANOVA with post hoc Tukey's correction were used. The area under the receiveroperating characteristic (ROC) curve (AUC) for detection of different contractile states was also used for comparison of the methods. We also calculated the intervals given by mean + 2SD for indices at rest and during the different contractile states and compared the percentage overlap relative to the mean at rest of these intervals.
Data reproducibility
Reproducibility was tested on a different population in relation to the HUNT study, and the results are published elsewhere. 6, 7 The inter-observer mean error (the percentage difference between two experienced physician echocardiographers' measurements on separate recordings) was 7 -10% for the peak systolic velocity indices and 4 -14% for the end-systolic indices.
Results
Study population and feasibility Table 1 shows the basic characteristics of the study population, and Table S1 , were also feasible in all recordings. One thousand and eighty-four (83%) segments postprocessed by 2D-ST and 1120 (85%) segments post-processed by the TD velocity gradient method were accepted for analysis. The rest of the segments were excluded because of reverberations, valvular interference, or tracking difficulties. The percentages of rejected segments were 14% at rest, 20% during dobutamine stress, and 15% after injection of metoprolol.
Systolic indices during low-dose dobutamine stress Table 3 shows the mean (SD) at rest and during stress, and the effect of stress, for all the systolic indices of LV performance. All indices increased significantly (all P , 0.001) from rest to stress. The relative increase in the peak velocity indices ranged from 51 to 62%, and these changes were significantly higher (all P , 0.05) than the relative changes of all end-systolic indices which ranged from 21 to 31%. In the ROC analysis, the AUC was between 0.93 and 1.00 for all methods, and differences between peak velocity-and end-systolic indices were not significant. The range and the mean + 2SD at rest and during stress overlapped for all indices except S ′ (spectral TD), S ′ (colour TD), and SR S (TD) ( Table 3 and Figure 2 ). .......... ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ .... ..... Contraction changes assessed by echocardiography in young healthy humans low-dose dobutamine. All indices decreased significantly after injection of metoprolol (all P , 0.05), except global strain, MAE (M-mode), and 2D LVEF. The relative changes of the peak velocity indices ranged from 215 to 211% and the relative changes of all end-systolic indices ranged from 25 to 1%. There was a trend for all peak systolic indices to have higher AUC for detection of decreased contraction compared with the end-systolic indices, and this was significant for SR S (TD) compared with all end-systolic indices and for S ′ (spectral TD) compared with global strain, MAE (M-mode), and 2D LVEF. The range and the mean + 2SD at rest and after injection of metoprolol overlapped for all indices.
Systolic indices after metoprolol
Discussion
To our knowledge, this is the first study that directly compares the influence of contractility changes on LVEF, traditional Doppler indices, TD indices, and newer speckle-tracking-based indices in the same human data set. In this study, peak systolic velocity indices exhibited greater variation than end-systolic indices during inotropic alterations. We suggest from this that the peak systolic velocity indices better reflected LV contraction.
Study population and study design
We randomly selected a study population from a relatively homogenous sample of young and healthy subjects. The population was chosen in order to induce uniform alterations in contraction and avoid any pathological response to dobutamine or metoprolol. The main effect of dobutamine at low dose is increased inotropy without a profound effect on heart rate, 8 and it is thus well suited for studying changes in contraction. In line with previous studies, low-dose dobutamine increased the heart rate by 13% 9,10 and metoprolol reduced the heart rate by 12%. No invasive reference method was used, but dobutamine and metoprolol have well-documented positive and negative inotropic effects, and has previously been used to define inotropic states in several studies. 3, 8, 10, 11 Low-dose dobutamine has previously induced .50% increase in the maximal first derivative of LV pressure (LV dP/dt max ) obtained by cardiac catheterization in different populations, 12 -14 which is in the same range as the measured increase in peak systolic velocity indices during low-dose dobutamine in this study.
Peak systolic vs. end-systolic indices
The study shows a significantly different response to positive and negative inotropic stimulation between peak systolic velocity indices and end-systolic indices. This is supported by findings in several previous studies: inotropic alterations affected the peak velocity considerably more than the velocity time integral of LVOT and aortic blood velocity waveform in two studies. 8, 15 In studies of patients with heart disease, S ′ had a better correlation to LV pressure development than LVEF, MAE, and LVOT vti. 16 ,17 S ′ Figure 2 The response to dobutamine and b-blocker of peak systolic annulus velocity, ejection fraction, and global strain. Individual changes of peak systolic velocity spectral tissue Doppler mitral annulus velocities [S ′ (sTD)], ejection fraction (EF), and global strain at rest, during low-dose dobutamine (upper panels), and after injection of metoprolol (lower panels). The mean (wide line), the mean + 2SD (narrow line), and the P-value of the change are displayed for each variable. The relative change during stress and after injection of metoprolol was highest for S ′ (sTD).
A. Thorstensen et al. increased considerably more than LVEF, FS, and e ′ during low-dose dobutamine in a study on healthy humans. 9 S ′ , LVOT peak, and peak SR S are almost simultaneous events in the heart cycle, 18 and their timing corresponds well to the timing of peak force development on a myocyte level, which occurs in the first part of systole. 19 End-systolic indices are much less dependent of the temporal component of deformation compared with peak systolic indices, and end-systolic indices are more related to stroke volume, i.e. the total amount of work performed by the ventricle during systole. This is influenced not only by contractility (force), but also by afterload, as well as the total time span of the work. Thus, end-systolic indices are more heart rate-sensitive than peak systolic indices, and the modest changes in heart rate induced by inotropic alterations in this study could partly explain the less pronounced changes of the end-systolic indices. However, according to other studies, such modest changes in heart rate have negligible influence on Doppler myocardial imaging parameters. 20, 21 Furthermore, SR S showed larger variation and better correlation to LV pressure development compared with end-systolic strain during inotropic alterations independent of heart rate in the study of atrial paced pigs. 3 Clinical implications of our study LVEF is a key functional and prognostic marker of LV function. However, LVEF overestimates the myocardial function in small hypertrophic hearts, has limited reproducibility, and is a poor indicator of the contractile properties of the myocardium. 1 The present and other studies 22 -24 indicate that peak systolic velocity indices give important supplementary information to LVEF and global strain. In this study, peak systolic velocity indices were more sensitive in detecting contraction changes, and therefore, it may be suggested that peak systolic velocity indices are more sensitive to detect changes of cardiac function also in clinical practice.
However, this has to be tested in a clinical setting. Compared with deformation imaging, indices of annular tissue velocities appear superior with respect to feasibility and time efficiency. Thus, the average peak systolic mitral annulus tissue velocity currently seems to be the preferred marker of contraction among frequently used echocardiographic methods in everyday clinical practice. As real-time 3D echocardiography with low frame rate is now available in clinical practice, it is important to keep in mind that peak systolic indices require higher frame rate than end-systolic indices.
Limitations
The subjects were fairly young and without heart disease, which probably gave a more homogenous response to inotropic alterations than would have been expected in a general population. It remains to be tested whether our results could be extrapolated to a more general population of patients with heart disease or whether our results are useful for predicting outcomes during longer-term follow-up in patients with heart disease. In addition, the present study addresses only global indices, and regional indices may perform better in conditions with regional dysfunction. In seven subjects, recordings under the influence of metoprolol were obtained after infusion of dobutamine. Although metoprolol was given at least 20 min after dobutamine was discontinued, there was a trend (P ¼ 0.10) for a smaller decrease in heart rate among these seven subjects. However, the effect of metoprolol on any of the echocardiographic indices did not differ significantly (all P . 0.12) in these 7 subjects compared with the 13 subjects who did not receive dobutamine before metoprolol. Parameters of twist and torsion were not available in the present study. nuclear imaging. The subjects were not examined during changes in loading conditions.
Conclusion
Peak systolic velocity indices (peak systolic mitral annulus tissue velocities, ejection velocities, and peak systolic strain rate) exhibited greater variation than end-systolic indices during inotropic alterations from which it is assumed that they better reflected LV contraction. Considering feasibility and time efficiency, peak systolic annulus tissue velocity seems to be the preferred marker of contraction among frequently used echocardiographic methods.
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